HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Ochiya Selected Research

Intravenous Injections

1/2017Amigo2-upregulation in Tumour Cells Facilitates Their Attachment to Liver Endothelial Cells Resulting in Liver Metastases.
1/2016PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma.
6/2011MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Ochiya Research Topics

Disease

193Neoplasms (Cancer)
03/2024 - 03/2002
43Neoplasm Metastasis (Metastasis)
06/2023 - 08/2005
40Breast Neoplasms (Breast Cancer)
03/2024 - 09/2008
18Carcinogenesis
12/2023 - 03/2002
15Prostatic Neoplasms (Prostate Cancer)
01/2023 - 08/2005
11Sarcoma (Soft Tissue Sarcoma)
09/2021 - 02/2012
11Stomach Neoplasms (Stomach Cancer)
09/2021 - 07/2006
11Lung Neoplasms (Lung Cancer)
09/2021 - 11/2013
10Fibrosis (Cirrhosis)
01/2024 - 04/2005
10Carcinoma (Carcinomatosis)
01/2023 - 11/2003
9Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 01/2016
9Infections
11/2019 - 06/2008
8Hepatocellular Carcinoma (Hepatoma)
12/2023 - 02/2006
8Osteosarcoma (Osteogenic Sarcoma)
06/2023 - 06/2011
8Liver Neoplasms (Liver Cancer)
09/2021 - 11/2009
7Inflammation (Inflammations)
05/2024 - 03/2004
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 01/2011
7Urinary Bladder Neoplasms (Bladder Cancer)
12/2022 - 03/2013
7Liver Diseases (Liver Disease)
02/2020 - 07/2007
6Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 12/2009
6Adenocarcinoma
10/2022 - 12/2006
5Disease Progression
01/2023 - 03/2013
4Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2023 - 11/2019
4Adenocarcinoma of Lung
01/2023 - 08/2014
4Dementia (Dementias)
11/2021 - 01/2019
4Alzheimer Disease (Alzheimer's Disease)
10/2021 - 01/2013
3Virus Diseases (Viral Diseases)
12/2023 - 05/2007
3Mouth Neoplasms (Oral Cancer)
12/2023 - 02/2018
3Hypoxia (Hypoxemia)
11/2023 - 10/2012
3Ovarian Epithelial Carcinoma
01/2023 - 04/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 05/2016
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 01/2018
3Colonic Neoplasms (Colon Cancer)
12/2021 - 10/2018
3Glioma (Gliomas)
12/2019 - 06/2007
3Hepatitis B
01/2019 - 11/2013
3Synovial Sarcoma (Synovioma)
11/2018 - 11/2017
3Ascites
01/2017 - 08/2006
3Liver Failure
01/2012 - 02/2010
2Circulating Neoplastic Cells
12/2023 - 10/2021
2Obesity
01/2023 - 10/2022
2Non-alcoholic Fatty Liver Disease
12/2022 - 09/2013
2Multiple Myeloma
01/2022 - 03/2018
2Brain Neoplasms (Brain Tumor)
09/2021 - 12/2019
2Esophageal Neoplasms (Esophageal Cancer)
09/2021 - 01/2019
2Head and Neck Neoplasms (Head and Neck Cancer)
04/2020 - 02/2018
2Esophageal Squamous Cell Carcinoma
02/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

149MicroRNAs (MicroRNA)IBA
05/2024 - 11/2009
68Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2006
32Proteins (Proteins, Gene)FDA Link
05/2024 - 07/2002
20Small Interfering RNA (siRNA)IBA
05/2016 - 07/2004
11atelocollagenIBA
01/2020 - 11/2003
10Messenger RNA (mRNA)IBA
09/2020 - 03/2004
8RNA (Ribonucleic Acid)IBA
09/2022 - 07/2014
7Therapeutic UsesIBA
01/2024 - 04/2005
6CytokinesIBA
05/2024 - 10/2012
6LigandsIBA
05/2023 - 07/2006
6Docetaxel (Taxotere)FDA Link
06/2020 - 09/2008
6ribophorinIBA
06/2015 - 01/2013
5Peptides (Polypeptides)IBA
12/2021 - 01/2013
5AntibodiesIBA
12/2021 - 04/2014
5Cisplatin (Platino)FDA LinkGeneric
11/2020 - 02/2015
5DNA (Deoxyribonucleic Acid)IBA
09/2020 - 07/2013
5LuciferasesIBA
01/2017 - 07/2004
4Antiviral Agents (Antivirals)IBA
12/2023 - 01/2019
4Membrane Proteins (Integral Membrane Proteins)IBA
01/2023 - 06/2015
4Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 02/2006
4Circulating MicroRNAIBA
12/2022 - 10/2010
4InterferonsIBA
03/2021 - 02/2012
4PlatinumIBA
11/2020 - 04/2015
3CateninsIBA
01/2024 - 12/2014
3Immune Checkpoint InhibitorsIBA
05/2023 - 11/2022
3Phenobarbital (Luminal)FDA Link
09/2022 - 06/2015
3Conditioned Culture MediaIBA
09/2022 - 11/2018
3LipidsIBA
09/2020 - 04/2016
3Long Noncoding RNAIBA
09/2020 - 07/2018
3OligonucleotidesIBA
04/2019 - 03/2004
3ResveratrolIBA
05/2018 - 01/2012
3Antineoplastic Agents (Antineoplastics)IBA
10/2016 - 08/2006
3TransferasesIBA
02/2015 - 05/2014
3Hyaluronic Acid (Hyaluronan)IBA
07/2014 - 09/2010
2Untranslated RNA (Noncoding RNA)IBA
03/2024 - 03/2019
2Circulating Tumor DNAIBA
12/2023 - 10/2021
2Immune Checkpoint ProteinsIBA
01/2023 - 01/2019
2AntigensIBA
01/2023 - 01/2021
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2023 - 03/2004
2NivolumabIBA
11/2022 - 02/2020
2Transforming Growth Factors (Transforming Growth Factor)IBA
09/2022 - 01/2015
2Programmed Cell Death 1 ReceptorIBA
01/2021 - 02/2020
2Hormones (Hormone)IBA
01/2021 - 01/2020
2AndrogensIBA
01/2021 - 06/2008

Therapy/Procedure

68Therapeutics
03/2024 - 09/2006
10Transplantation
11/2023 - 04/2005
8Drug Therapy (Chemotherapy)
06/2023 - 04/2014
5RNAi Therapeutics
03/2015 - 01/2012
3Intravenous Injections
01/2017 - 06/2011
2Neoadjuvant Therapy
04/2024 - 03/2011
2Intravenous Administration
01/2023 - 01/2021
2Radiotherapy
01/2022 - 04/2008
2Adjuvant Chemotherapy
01/2020 - 05/2016
2Aftercare (After-Treatment)
01/2020 - 11/2019